Lansdowne Partners Austria GmbH Shows New 10.7% Stake in Alexza Pharma (ALXA)
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Join SI Premium – FREE
In a 13G filing on Alexza Pharmaceuticals (NASDAQ: ALXA), hedge fund Lansdowne Partners Austria GmbH disclosed a 10.74%, or 1,690,610 share, stake in the company.
The firm did not hold shares at the end of the latest quarter ending September 30, 2012.
For more notable holders of Alexza Pharmaceuticals stock click here.
The firm did not hold shares at the end of the latest quarter ending September 30, 2012.
For more notable holders of Alexza Pharmaceuticals stock click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- D.E. Shaw owns $1B+ stake in Sysco - Reuters
- Kanen Wealth Management urges Zevia to explore a sale
- Engine Capital urges H.B. Fuller to explore BAS and full sale
Create E-mail Alert Related Categories
13Gs, Hedge FundsRelated Entities
Hedge Funds, Lansdowne Partners, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
